You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

December 12, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Possible link between statin use and cataracts, but weigh risks and benefits

Patients taking statins may be at an increased risk for cataracts, according to a study published in the Canadian Journal of Cardiology. » Read about the study and accompanying editorial

Optimal combination of secondary prevention drug classes after recent ischemic stroke may lower recurrent stroke risk

For recent ischemic stroke patients, using an optimal combination of evidence-based secondary prevention medication classes, compared to not doing so, was associated with 61% lower odds of experiencing a recurrent stroke, according to a study published online in Neurology. » Recurrent stroke effects can be more disabling than prior event

Continuing Education

MTM essentials for weight management

This month's CE activity is part of a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month’s activity is to assist pharmacists in providing smoking cessation services for patients interested in quitting smoking.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT13-KCE28.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

FDA panel recommends Actavis' antibiotic for approval

Actavis Plc has announced that the Infective Drugs Advisory Committee has voted to recommend approval of its New Drug Application for ceftazidime-avibactam. » Read more about this investigational antibiotic

 

RELATED ARTICLES

Types of cataracts and their underlying conditions

[BLOG] The acute coronary syndrome pipeline: Novel therapies targeting unmet needs in niche patient populations

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group